Redefining Prognosis of Transthyretin Cardiomyopathy in the Tafamidis Era.

Zaghlol, Raja; Rater, Molly; Schiffer, Walter; Mitchell, Joshua D

Zaghlol, Raja; Rater, Molly; Schiffer, Walter; Mitchell, Joshua D.

Afiliação

Zaghlol R; Amyloid Center of Excellence, Cardiovascular Division, Washington University School of Medicine in St. Louis, St. Louis, Missouri.
Rater M; Amyloid Center of Excellence, Cardiovascular Division, Washington University School of Medicine in St. Louis, St. Louis, Missouri.
Schiffer W; Amyloid Center of Excellence, Cardiovascular Division, Washington University School of Medicine in St. Louis, St. Louis, Missouri.
Mitchell JD; Amyloid Center of Excellence, Cardiovascular Division, Washington University School of Medicine in St. Louis, St. Louis, Missouri. Electronic address: jdmitchell@wustl.edu.

J Card Fail ; 28(10): 1519-1521, 2022 10.

Article em En | MEDLINE | ID: mdl-35988721

Assuntos

Neuropatias Amiloides Familiares; Cardiomiopatias; Insuficiência Cardíaca; Neuropatias Amiloides Familiares/diagnóstico; Neuropatias Amiloides Familiares/tratamento farmacológico; Benzoxazóis; Cardiomiopatias/diagnóstico; Cardiomiopatias/tratamento farmacológico; Humanos; Pré-Albumina/genética; Prognóstico

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neuropatias Amiloides Familiares / Insuficiência Cardíaca / Cardiomiopatias Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Humans Idioma: En Revista: J Card Fail Assunto da revista: CARDIOLOGIA Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google